Liquidia (LQDA) Other Non-Current Liabilities (2020 - 2026)

Liquidia's (LQDA) quarterly Other Non-Current Liabilities came in at $8.5 million in Q1 2026, up 13.43% year-on-year from $7.5 million in Q1 2025, and up 1.94% quarter-over-quarter from $8.4 million in Q4 2025.

Liquidia (LQDA) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Liquidia's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $8.5 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 13.43% year-over-year to $8.5 million in Q1 2026; TTM through Mar 2026 was $8.5 million, a 13.43% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, up 14.85% from the prior year.
  • Other Non-Current Liabilities grew to $8.5 million in Q1 2026 per LQDA's latest filing, from $8.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $8.5 million in Q1 2026 and bottomed at $6.4 million in Q1 2022.
  • The 5-year median for Other Non-Current Liabilities is $6.7 million (2024), against an average of $7.2 million.
  • Across the five-year window, Other Non-Current Liabilities soared 208.42% in 2022 and advanced 1.5% in 2024, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $6.6 million in 2022, then rose by 1.71% to $6.7 million in 2023, then rose by 8.84% to $7.3 million in 2024, then grew by 14.85% to $8.4 million in 2025, then grew by 1.94% to $8.5 million in 2026.
  • Per Business Quant, the three latest LQDA Other Non-Current Liabilities figures stand at $8.5 million (Q1 2026), $8.4 million (Q4 2025), and $8.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.55 Mn
Dec 31, 2025 8.38 Mn
Sep 30, 2025 8.28 Mn
Jun 30, 2025 7.97 Mn
Mar 31, 2025 7.54 Mn
Dec 31, 2024 7.30 Mn
Sep 30, 2024 7.20 Mn
Jun 30, 2024 6.93 Mn
Mar 31, 2024 6.71 Mn
Dec 31, 2023 6.71 Mn
Sep 30, 2023 6.70 Mn
Jun 30, 2023 6.70 Mn
Mar 31, 2023 6.61 Mn
Dec 31, 2022 6.59 Mn
Sep 30, 2022 6.56 Mn
Jun 30, 2022 6.51 Mn
Mar 31, 2022 6.42 Mn
Dec 31, 2021 6.14 Mn
Sep 30, 2021 5.07 Mn
Jun 30, 2021 3.00 Mn